Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.

Article  PubMed  PubMed Central  Google Scholar 

Rivero JR, De La Cerda J, Wang H, Liss MA, Farrell AM, Rodriguez R, et al. Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. J Vasc Interv Radiol. 2018;29:18–29.

Article  PubMed  Google Scholar 

Zondervan PJ, Buijs M, De Bruin DM, van Delden OM, Van Lienden KP. Available ablation energies to treat cT1 renal cell cancer: emerging technologies. World J Urol. 2019;37:445–55.

Article  CAS  PubMed  Google Scholar 

Salagierski M, Wojciechowska A, Zajac K, Klatte T, Thompson RH, Cadeddu JA. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. Eur Urol Oncol. 2018;1:395–402.

Article  PubMed  Google Scholar 

Bi Y, Shi X, Ren J, Yi M, Han X. Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads. Sci Rep. 2022;12:8136.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leopold Z, Passarelli R, Mikhail M, Tabakin A, Chua K, Ennis RD. Modern Management of Localized Renal Cell Carcinoma—Is Ablation Part of the Equation? J Kidney Cancer Vhl. 2022;9:5–23.

Article  PubMed  PubMed Central  Google Scholar 

Bisbee CA 2nd, Zhang J, Owens J, Hussain S. Cryoablation for the Treatment of Kidney Cancer: Comparison With Other Treatment Modalities and Review of Current Treatment. Cureus. 2022;14:e31195.

PubMed  PubMed Central  Google Scholar 

Breen DJ, King AJ, Patel N, Lockyer R, Hayes M. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5‑year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma. Radiology. 2018;289:554–61.

Article  PubMed  Google Scholar 

Stacul F, Sachs C, Giudici F, Bertolotto M, Rizzo M, Pavan N. Cryoablation of renal tumors: long-term follow-up from a multicenter experience. Abdom Radiol (ny). 2021;46:4476–88.

Article  PubMed  Google Scholar 

Aoun HD, Littrup PJ, Jaber M, Memon F, Adam B, Krycia M. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift? J Vasc Interv Radiol. 2017;28:1363–70.

Article  PubMed  Google Scholar 

Hasegawa T, Yamanaka T, Gobara H, Miyazaki M, Takaki H, Sato Y. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study. Jpn J Radiol. 2018;36:551–8.

Article  PubMed  Google Scholar 

Shi H, Li J, Fan Z, Yang J, Fu S, Wang H. Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes. Front Oncol. 2022;12:802437.

Article  PubMed  PubMed Central  Google Scholar 

Zeng JY, Piao XH, Zou ZY, Yang QF, Qin ZL, Chen JB. Cryoablation with drug-loaded bead embolization in the treatment of unresectable hepatocellular carcinoma: safety and efficacy analysis. Oncotarget. 2018;9:7557–66.

Article  PubMed  PubMed Central  Google Scholar 

Xu KC, Niu LZ, Zhou Q, Hu YZ, Guo DH, Liu ZP. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol. 2009;15:3664–9.

Article  PubMed  PubMed Central  Google Scholar 

Mikhail AS, Pritchard WF, Negussie AH, Krishnasamy VP, Amchin DB, Thompson JG. Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model. Radiology. 2018;289:396–404.

Article  PubMed  Google Scholar